D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Hi. Good morning, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Thank you for joining us here in Sunny Miami. Very happy to have 4D Molecular Therapeutics here with us today ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:30 PM EDTCompany ParticipantsNeil Kumar - Co-Founder, ...
Between monitoring blood sugar levels and scouring mixer ingredients, navigating chronic illness at university isn't for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results